February 18, 2022 — GE Healthcare has announced that it has received approval from the European Medicines Agency (EMA) for additional imaging modalities for its stress agent Rapiscan (Regadenoson).

We are launching something new—a Clinical Case of the Month—and we want you to contribute! Do you have a clinical case you’d like to share with DAIC's audience? If so, please send high-resolution images and a brief written case study to [email protected]

Share your unique cases with your peers! The Clinical Case of the Month will be updated regularly, and featured both online and in the digital edition of DAIC.

February 17, 2022 — While cardiac imaging shows that COVID-19 vaccine–associated myocarditis has a similar pattern as that from other causes, the abnormalities are less severe and result in less functional impairment, suggests a study yesterday in Radiology.

In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human. This was the first successful transplant of a genetically modified pig’s heart into a human patient.

In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human.

February 16, 2022 – Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, has announced completion of enrollment in the BIOADAPTOR randomized controlled trial (RCT).

February 16, 2022 – Cardiology is an inherently data-dependent and data-driven practice. Patient medical history records, images, test results, and more go into every diagnosis and treatment decision. However, most organizations don’t take advantage of structured reporting, most cardiovascular information systems (CVIS) cannot effectively mine the wealth of data from a facility’s cardiology department. There is no debate on how crucial structured reporting is.

February 16, 2022 – Inari Medical, Inc. has announced that the first patient has been enrolled in PEERLESS, a prospective, randomized controlled trial comparing the outcomes of patients with intermediate-high risk pulmonary embolism (PE) treated with the FlowTriever system versus

February 16, 2022 – The Heart Institute at Children’s Hospital Colorado (Children’s Colorado) has performed its 500th pediatric heart transplant, a milestone that only a few centers across the country have reached.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now